April 10, 2025 14:15 ET | Source: Transgene S.A. Transgene S.A.
Document d'Enregistrement Universel 2024
Pièces jointes
Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate at WCID
Transgene Expands myvac® into Non-Small Cell Lung Cancer with TG4070, an Individualized Neoantigen Therapeutic Vaccine
